CANNABIS POLAND AB ZY-10 - Asset Resilience Ratio

Latest as of December 2025: 57.87%

CANNABIS POLAND AB ZY-10 (8TE) has an Asset Resilience Ratio of 57.87% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 8TE total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

€1.74 Million

≈ $2.04 Million USD Cash + Short-term Investments

Total Assets

€3.01 Million

≈ $3.52 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2023–2025)

This chart shows how CANNABIS POLAND AB ZY-10's Asset Resilience Ratio has changed over time. See 8TE book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down CANNABIS POLAND AB ZY-10's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CANNABIS POLAND AB ZY-10 stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€1.74 Million	57.87%
Total Liquid Assets	€1.74 Million	57.87%

Asset Resilience Insights

Very High Liquidity: CANNABIS POLAND AB ZY-10 maintains exceptional liquid asset reserves at 57.87% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

CANNABIS POLAND AB ZY-10 Industry Peers by Asset Resilience Ratio

Compare CANNABIS POLAND AB ZY-10's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Daihan Pharmaceutical Co.Ltd KQ:023910	Drug Manufacturers - Specialty & Generic	11.95%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	16.92%
China Resources Sanjiu Medical & Pharmaceutical Co Ltd SHE:000999	Drug Manufacturers - Specialty & Generic	5.22%
Ningbo Menovo Pharm Co Ltd SHG:603538	Drug Manufacturers - Specialty & Generic	2.69%
Zhejiang Xianju Pharmaceutical Co Ltd SHE:002332	Drug Manufacturers - Specialty & Generic	6.02%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Hainan Honz Pharmaceutical Co SHE:300086	Drug Manufacturers - Specialty & Generic	0.27%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%

Annual Asset Resilience Ratio for CANNABIS POLAND AB ZY-10 (2023–2025)

The table below shows the annual Asset Resilience Ratio data for CANNABIS POLAND AB ZY-10.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	57.87%	€1.74 Million ≈ $2.04 Million	€3.01 Million ≈ $3.52 Million	-16.04pp
2024-12-31	73.90%	€3.09 Million ≈ $3.62 Million	€4.19 Million ≈ $4.90 Million	+10.44pp
2023-12-31	63.46%	€1.16 Million ≈ $1.36 Million	€1.84 Million ≈ $2.15 Million	--

pp = percentage points

About CANNABIS POLAND AB ZY-10

F:8TE Germany Drug Manufacturers - Specialty & Generic

Market Cap

$1.75 Million

€1.50 Million EUR

Market Cap Rank

#29819 Global

#2614 in Germany

Share Price

€0.03

Change (1 day)

+0.00%

52-Week Range

€0.02 - €0.10

All Time High

€0.69